NEW HAVEN, Conn. (WTNH) — Stroke is a leading cause of death and disability worldwide. Most cases are preventable. Kelly Matmati, MD, a neurologist at the Hartford HealthCare St. Vincent’s Medical ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ischemic stroke have been granted approval by the US Food and Drug ...
The 5-second intravenous bolus offers faster, simpler administration than Activase. (HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or ...
Neurosurgeon Dr. Rahul Jandial discusses the warning signs of a stroke, the symptoms to look out for, and how to approach treatment. For more on this topic, you can visit CityOfHope.org and follow Dr.
TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...
The FDA approved tenecteplase (TNKase) for adult stroke patients, Genentech announced on Monday. A clot-dissolving tissue plasminogen activator (tPA), tenecteplase is now indicated for acute ischemic ...
Children’s Minnesota is pleased to announce a $2.5 million, state-of-the-art biplane neuroangiography suite—the region’s only ...
The American Heart Association released a scientific statement on preventing and treating maternal stroke during pregnancy and postpartum.
There are more well-founded therapy options for the treatment of strokes than ever before. Care has to be reorganised before these innovations are actually used on patients. At the Congress of the ...
KPJ Healthcare Berhad launched its first Neuroscience and Stroke Centre of Excellence (CoE) at Damansara Specialist Hospital 2 (DSH2), marking the second Centre of Excellence established under the KPJ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results